Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,9.99515595402976e-06,5.1565029681597405,59.3689327712397,"['RPL30', 'RPL21', 'RPL34', 'RPL10A', 'RPL9', 'RPL7', 'RPS4X', 'RPS15A', 'RPL26', 'FAU', 'RPL18', 'RPL17', 'RPS12']",0.001539254016920583,0,0,13
2,7-oxo-C and 7beta-HC pathways WP5064,0.0015072543907229514,inf,inf,"['DBP', 'ACOT7']",0.11605858808566726,0,0,2
3,Oxysterols derived from cholesterol WP4545,0.004406141813674413,50.11666666666667,271.87068041337744,"['DBP', 'ACOT7']",0.22618194643528655,0,0,2
4,Monoamine Transport WP727,0.013948904689215851,16.694444444444443,71.32458135306607,"['SLC6A1', 'STX1A']",0.42962626442784824,0,0,2
5,One-carbon metabolism WP241,0.013948904689215851,16.694444444444443,71.32458135306607,"['DNMT1', 'GART']",0.42962626442784824,0,0,2
6,Cytosolic DNA-sensing pathway WP4655,0.030727715274490957,5.030252100840336,17.518306941433586,"['POLR3A', 'IRF3', 'IL18']",0.5002104812678909,0,0,3
7,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.03617136179834777,8.338888888888889,27.680838129240826,"['P4HB', 'PPIB']",0.5002104812678909,0,0,2
8,MTHFR deficiency WP4288,0.03617136179834777,8.338888888888889,27.680838129240826,"['DNMT1', 'COMT']",0.5002104812678909,0,0,2
9,Serotonin Transporter Activity WP1455,0.038977440098796695,inf,inf,['STX1A'],0.5002104812678909,0,0,1
10,Biogenic Amine Synthesis WP550,0.038977440098796695,inf,inf,['COMT'],0.5002104812678909,0,0,1
11,Disorders of Folate Metabolism and Transport WP4259,0.038977440098796695,inf,inf,['GART'],0.5002104812678909,0,0,1
12,Estrogen metabolism WP697,0.038977440098796695,inf,inf,['COMT'],0.5002104812678909,0,0,1
13,Nuclear Receptors Meta-Pathway WP2882,0.0499722714248659,2.6923076923076925,8.06692653546857,"['SLC6A6', 'ALOX5AP', 'ARNT', 'PMP2', 'SLC6A1']",0.5318341615662446,0,0,5
14,Pathways in clear cell renal cell carcinoma WP4018,0.05183133896917498,3.9659442724458205,11.738244462146824,"['PGBD5', 'SSPN', 'ARNT']",0.5318341615662446,0,0,3
15,Type 2 papillary renal cell carcinoma WP4241,0.05525549730558386,6.25,18.09867152993967,"['DIAPH1', 'ARNT']",0.5318341615662446,0,0,2
16,Glycogen Synthesis and Degradation WP500,0.05525549730558386,6.25,18.09867152993967,"['PPP2R1A', 'CALM1']",0.5318341615662446,0,0,2
17,Hypertrophy Model WP516,0.07644771658222561,24.85123966942149,63.8962205208728,['IL18'],0.6541307007266565,0,0,1
18,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.07705626442939872,4.996666666666667,12.807553020723548,"['COPS6', 'IL18']",0.6541307007266565,0,0,2
19,Metabolic reprogramming in colon cancer WP4290,0.08881044072647944,4.540909090909091,10.994680950394137,"['SUCLG2', 'GART']",0.6541307007266565,0,0,2
20,Genotoxicity pathway WP4286,0.08881044072647944,4.540909090909091,10.994680950394137,"['CCP110', 'LRRFIP2']",0.6541307007266565,0,0,2
21,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.11246855831978433,12.421487603305785,27.141963733361703,['CDH2'],0.6541307007266565,0,0,1
22,Trans-sulfuration pathway WP2333,0.11246855831978433,12.421487603305785,27.141963733361703,['DNMT1'],0.6541307007266565,0,0,1
23,Cellular Proteostasis WP4918,0.11246855831978433,12.421487603305785,27.141963733361703,['PFDN5'],0.6541307007266565,0,0,1
24,Disorders of the Krebs cycle WP4236,0.11246855831978433,12.421487603305785,27.141963733361703,['SUCLG2'],0.6541307007266565,0,0,1
25,Dopamine metabolism WP2436,0.11246855831978433,12.421487603305785,27.141963733361703,['COMT'],0.6541307007266565,0,0,1
26,G13 Signaling Pathway WP524,0.14018477128457754,3.3255555555555554,6.534031374909618,"['DIAPH1', 'CALM1']",0.6541307007266565,0,0,2
27,Airway smooth muscle cell contraction WP4962,0.14709557404605983,8.278236914600551,15.866671028562136,['CALM1'],0.6541307007266565,0,0,1
28,Methylation Pathways WP704,0.14709557404605983,8.278236914600551,15.866671028562136,['COMT'],0.6541307007266565,0,0,1
29,Cytosine methylation WP3585,0.14709557404605983,8.278236914600551,15.866671028562136,['DNMT1'],0.6541307007266565,0,0,1
30,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.14709557404605983,8.278236914600551,15.866671028562136,['MYRIP'],0.6541307007266565,0,0,1
31,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.14709557404605983,8.278236914600551,15.866671028562136,['IRF3'],0.6541307007266565,0,0,1
32,Ganglio Sphingolipid Metabolism WP1423,0.14709557404605983,8.278236914600551,15.866671028562136,['ST8SIA3'],0.6541307007266565,0,0,1
33,Purine metabolism and related disorders WP4224,0.14709557404605983,8.278236914600551,15.866671028562136,['GART'],0.6541307007266565,0,0,1
34,Glucocorticoid Receptor Pathway WP2880,0.15386691054237783,3.1166666666666667,5.833362983636093,"['ALOX5AP', 'PMP2']",0.6541307007266565,0,0,2
35,Selenium Micronutrient Network WP15,0.1677952589902943,2.9323529411764704,5.234281491358359,"['ALOX5AP', 'SELENOH']",0.6541307007266565,0,0,2
36,Angiogenesis WP1539,0.18038226500350726,6.206611570247934,10.629920794174332,['ARNT'],0.6541307007266565,0,0,1
37,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.18038226500350726,6.206611570247934,10.629920794174332,['CALM1'],0.6541307007266565,0,0,1
38,Trans-sulfuration and one-carbon metabolism WP2525,0.18038226500350726,6.206611570247934,10.629920794174332,['DNMT1'],0.6541307007266565,0,0,1
39,NRF2 pathway WP2884,0.18193030248036635,2.7685185185185186,4.717919944240145,"['SLC6A6', 'SLC6A1']",0.6541307007266565,0,0,2
40,VEGFA-VEGFR2 Signaling Pathway WP3888,0.19590710787136895,1.5312665406427222,2.4961400539219363,"['RACK1', 'ARNT', 'LRRFIP2', 'P4HB', 'RPL26', 'RPL10A', 'RPL7']",0.6541307007266565,0,0,7
41,Pyrimidine metabolism WP4022,0.19623518734264664,2.6219298245614033,4.269659083851551,"['PNPT1', 'POLR3A']",0.6541307007266565,0,0,2
42,Sleep regulation WP3591,0.2123800976385248,4.963636363636364,7.690547474220441,['IL18'],0.6541307007266565,0,0,1
43,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.2123800976385248,4.963636363636364,7.690547474220441,['SUCLG2'],0.6541307007266565,0,0,1
44,Development and heterogeneity of the ILC family WP3893,0.2123800976385248,4.963636363636364,7.690547474220441,['IL18'],0.6541307007266565,0,0,1
45,DNA Mismatch Repair WP531,0.2123800976385248,4.963636363636364,7.690547474220441,['MSH2'],0.6541307007266565,0,0,1
46,Eicosanoid Synthesis WP167,0.2123800976385248,4.963636363636364,7.690547474220441,['ALOX5AP'],0.6541307007266565,0,0,1
47,Endothelin Pathways WP2197,0.2123800976385248,4.963636363636364,7.690547474220441,['CALM1'],0.6541307007266565,0,0,1
48,Oxidation by Cytochrome P450 WP43,0.2123800976385248,4.963636363636364,7.690547474220441,['CYB5B'],0.6541307007266565,0,0,1
49,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.2123800976385248,4.963636363636364,7.690547474220441,['GTPBP4'],0.6541307007266565,0,0,1
50,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.2123800976385248,4.963636363636364,7.690547474220441,['DNMT1'],0.6541307007266565,0,0,1
51,IL1 and megakaryocytes in obesity WP2865,0.24313857888106605,4.134986225895317,5.847382082121411,['IL18'],0.6773648511487248,0,0,1
52,White fat cell differentiation WP4149,0.24313857888106605,4.134986225895317,5.847382082121411,['IRF3'],0.6773648511487248,0,0,1
53,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.24313857888106605,4.134986225895317,5.847382082121411,['ARNT'],0.6773648511487248,0,0,1
54,Physiological and pathological hypertrophy of the heart WP1528,0.24313857888106605,4.134986225895317,5.847382082121411,['CALM1'],0.6773648511487248,0,0,1
55,SARS coronavirus and innate immunity WP4912,0.24313857888106605,4.134986225895317,5.847382082121411,['IRF3'],0.6773648511487248,0,0,1
56,mRNA Processing WP411,0.2545012857883345,2.1630434782608696,2.9600155300801587,"['SNRPD1', 'SRSF3']",0.6773648511487248,0,0,2
57,Alzheimer's disease WP2059,0.2691859588911406,2.0722222222222224,2.71948672097859,"['CAPN1', 'CALM1']",0.6773648511487248,0,0,2
58,TLR4 Signaling and Tolerance WP3851,0.27270532968325284,3.543093270365998,4.603765878430828,['IRF3'],0.6773648511487248,0,0,1
59,Microglia Pathogen Phagocytosis Pathway WP3937,0.27270532968325284,3.543093270365998,4.603765878430828,['CYBA'],0.6773648511487248,0,0,1
60,Folate Metabolism WP176,0.27270532968325284,3.543093270365998,4.603765878430828,['GART'],0.6773648511487248,0,0,1
61,Prostaglandin Synthesis and Regulation WP98,0.27270532968325284,3.543093270365998,4.603765878430828,['ANXA4'],0.6773648511487248,0,0,1
62,SARS-CoV-2 mitochondrial interactions WP5038,0.27270532968325284,3.543093270365998,4.603765878430828,['IRF3'],0.6773648511487248,0,0,1
63,Integrated breast cancer pathway WP1984,0.29852431940091545,1.9115384615384616,2.3108662580262473,"['MSH2', 'FAU']",0.6819621769971601,0,0,2
64,Intraflagellar transport proteins binding to dynein WP4532,0.3011261560766681,3.0991735537190084,3.719708612177316,['DYNC2H1'],0.6819621769971601,0,0,1
65,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.3011261560766681,3.0991735537190084,3.719708612177316,['IRF3'],0.6819621769971601,0,0,1
66,Aryl Hydrocarbon Receptor Pathway WP2873,0.3011261560766681,3.0991735537190084,3.719708612177316,['ARNT'],0.6819621769971601,0,0,1
67,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.3011261560766681,3.0991735537190084,3.719708612177316,['SUCLG2'],0.6819621769971601,0,0,1
68,Regulation of Microtubule Cytoskeleton WP2038,0.3011261560766681,3.0991735537190084,3.719708612177316,['DIAPH1'],0.6819621769971601,0,0,1
69,Ciliary landscape WP4352,0.3198126992167812,1.5546218487394958,1.7722996416590244,"['COPS6', 'MSH2', 'CALM1']",0.6928842208888869,0,0,3
70,G Protein Signaling Pathways WP35,0.32768367227767214,1.7738095238095237,1.9790509036908777,"['PDE8B', 'CALM1']",0.6928842208888869,0,0,2
71,Melatonin metabolism and effects WP3298,0.32844511769408274,2.753902662993572,3.066155360692512,['CALM1'],0.6928842208888869,0,0,1
72,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.32844511769408274,2.753902662993572,3.066155360692512,['IRF3'],0.6928842208888869,0,0,1
73,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.32844511769408274,2.753902662993572,3.066155360692512,['CALM1'],0.6928842208888869,0,0,1
74,Aryl Hydrocarbon Receptor Netpath WP2586,0.3547045938041524,2.477685950413223,2.5680470729032225,['ARNT'],0.7045127070296239,0,0,1
75,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3547045938041524,2.477685950413223,2.5680470729032225,['MSH2'],0.7045127070296239,0,0,1
76,Joubert Syndrome WP4656,0.3799453467817943,2.2516904583020287,2.1790235905401465,['CCP110'],0.7045127070296239,0,0,1
77,Toll-like Receptor Signaling related to MyD88 WP3858,0.3799453467817943,2.2516904583020287,2.1790235905401465,['IRF3'],0.7045127070296239,0,0,1
78,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.3799453467817943,2.2516904583020287,2.1790235905401465,['IRF3'],0.7045127070296239,0,0,1
79,Parkinson's disease pathway WP2371,0.3799453467817943,2.2516904583020287,2.1790235905401465,['SYT11'],0.7045127070296239,0,0,1
80,22q11.2 copy number variation syndrome WP4657,0.40420658336877957,2.0633608815426996,1.8690525092811194,['COMT'],0.7045127070296239,0,0,1
81,Integrated Cancer Pathway WP1971,0.40420658336877957,2.0633608815426996,1.8690525092811194,['MSH2'],0.7045127070296239,0,0,1
82,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.40420658336877957,2.0633608815426996,1.8690525092811194,['CALM1'],0.7045127070296239,0,0,1
83,p53 transcriptional gene network WP4963,0.40420658336877957,2.0633608815426996,1.8690525092811194,['MSH2'],0.7045127070296239,0,0,1
84,Pathways affected in adenoid cystic carcinoma WP3651,0.40420658336877957,2.0633608815426996,1.8690525092811194,['NFIB'],0.7045127070296239,0,0,1
85,GABA receptor Signaling WP4159,0.40420658336877957,2.0633608815426996,1.8690525092811194,['SLC6A1'],0.7045127070296239,0,0,1
86,Genes related to primary cilium development (based on CRISPR) WP4536,0.40420658336877957,2.0633608815426996,1.8690525092811194,['DYNC2H1'],0.7045127070296239,0,0,1
87,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.40420658336877957,2.0633608815426996,1.8690525092811194,['IRF3'],0.7045127070296239,0,0,1
88,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.40420658336877957,2.0633608815426996,1.8690525092811194,['IRF3'],0.7045127070296239,0,0,1
89,CAMKK2  Pathway WP4874,0.42752601339236124,1.9040050858232676,1.6179095527882512,['CALM1'],0.7045127070296239,0,0,1
90,Wnt signaling pathway and pluripotency WP399,0.42752601339236124,1.9040050858232676,1.6179095527882512,['PPP2R1A'],0.7045127070296239,0,0,1
91,Circadian rhythm related genes WP3594,0.4399903811759857,1.375925925925926,1.1296385056693201,"['DBP', 'ARNT']",0.7045127070296239,0,0,2
92,Common Pathways Underlying Drug Addiction WP2636,0.4499399067102596,1.7674144037780402,1.4115300412410159,['CALM1'],0.7045127070296239,0,0,1
93,DNA IR-damage and cellular response via ATR WP4016,0.4499399067102596,1.7674144037780402,1.4115300412410159,['MSH2'],0.7045127070296239,0,0,1
94,Neural Crest Differentiation WP2064,0.4499399067102596,1.7674144037780402,1.4115300412410159,['CDH2'],0.7045127070296239,0,0,1
95,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.4499399067102596,1.7674144037780402,1.4115300412410159,['CDH2'],0.7045127070296239,0,0,1
96,AGE/RAGE pathway WP2324,0.471483147441379,1.6490358126721762,1.2398637225953815,['DIAPH1'],0.7045127070296239,0,0,1
97,NO/cGMP/PKG mediated Neuroprotection WP4008,0.471483147441379,1.6490358126721762,1.2398637225953815,['CALM1'],0.7045127070296239,0,0,1
98,Integrin-mediated Cell Adhesion WP185,0.4921892868227343,1.5454545454545454,1.0955602201635877,['CAPN1'],0.7045127070296239,0,0,1
99,Interferon type I signaling pathways WP585,0.4921892868227343,1.5454545454545454,1.0955602201635877,['RACK1'],0.7045127070296239,0,0,1
100,Endochondral Ossification with Skeletal Dysplasias WP4808,0.4921892868227343,1.5454545454545454,1.0955602201635877,['CALM1'],0.7045127070296239,0,0,1
101,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.4921892868227343,1.5454545454545454,1.0955602201635877,['IRF3'],0.7045127070296239,0,0,1
102,Endochondral Ossification WP474,0.4921892868227343,1.5454545454545454,1.0955602201635877,['CALM1'],0.7045127070296239,0,0,1
103,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.4921892868227343,1.5454545454545454,1.0955602201635877,['MSH2'],0.7045127070296239,0,0,1
104,Translation Factors WP107,0.512090593319316,1.4540593096742829,0.9731346159397215,['EIF2B3'],0.7045127070296239,0,0,1
105,Metapathway biotransformation Phase I and II WP702,0.512090593319316,1.4540593096742829,0.9731346159397215,['COMT'],0.7045127070296239,0,0,1
106,Corticotropin-releasing hormone signaling pathway WP2355,0.512090593319316,1.4540593096742829,0.9731346159397215,['IL18'],0.7045127070296239,0,0,1
107,Splicing factor NOVA regulated synaptic proteins WP4148,0.5312181016293585,1.3728191000918273,0.8684214818956274,['CDH2'],0.7045127070296239,0,0,1
108,Melanoma WP4685,0.5312181016293585,1.3728191000918273,0.8684214818956274,['CALM1'],0.7045127070296239,0,0,1
109,Cardiac Hypertrophic Response WP2795,0.5312181016293585,1.3728191000918273,0.8684214818956274,['CALM1'],0.7045127070296239,0,0,1
110,Ciliopathies WP4803,0.5312181016293585,1.3728191000918273,0.8684214818956274,['DYNC2H1'],0.7045127070296239,0,0,1
111,Disruption of postsynaptic signaling by CNV WP4875,0.5312181016293585,1.3728191000918273,0.8684214818956274,['STX1A'],0.7045127070296239,0,0,1
112,Pathways Regulating Hippo Signaling WP4540,0.5312181016293585,1.3728191000918273,0.8684214818956274,['CDH2'],0.7045127070296239,0,0,1
113,Proteasome Degradation WP183,0.5312181016293585,1.3728191000918273,0.8684214818956274,['PSMD5'],0.7045127070296239,0,0,1
114,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.5496016593431154,1.3001304915180514,0.7782080817651417,['CDH2'],0.7045127070296239,0,0,1
115,DNA Repair Pathways Full Network WP4946,0.5496016593431154,1.3001304915180514,0.7782080817651417,['MSH2'],0.7045127070296239,0,0,1
116,Phosphodiesterases in neuronal function WP4222,0.5496016593431154,1.3001304915180514,0.7782080817651417,['PDE8B'],0.7045127070296239,0,0,1
117,Prolactin Signaling Pathway WP2037,0.5496016593431154,1.3001304915180514,0.7782080817651417,['PPIB'],0.7045127070296239,0,0,1
118,Retinoblastoma gene in cancer WP2446,0.5496016593431154,1.3001304915180514,0.7782080817651417,['DNMT1'],0.7045127070296239,0,0,1
119,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.5648119426244708,1.0731884057971015,0.613072236025389,"['CDH2', 'RACK1']",0.7045127070296239,0,0,2
120,16p11.2 proximal deletion syndrome WP4949,0.5672699718939829,1.234710743801653,0.6999821502599181,['PPP2R1A'],0.7045127070296239,0,0,1
121,3q29 copy number variation syndrome WP4906,0.5672699718939829,1.234710743801653,0.6999821502599181,['DYNC2H1'],0.7045127070296239,0,0,1
122,Apoptosis WP254,0.5672699718939829,1.234710743801653,0.6999821502599181,['IRF3'],0.7045127070296239,0,0,1
123,MECP2 and Associated Rett Syndrome WP3584,0.5672699718939829,1.234710743801653,0.6999821502599181,['PSIP1'],0.7045127070296239,0,0,1
124,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5672699718939829,1.234710743801653,0.6999821502599181,['CDH2'],0.7045127070296239,0,0,1
125,Androgen receptor signaling pathway WP138,0.5842506460266887,1.175521448248721,0.6317548492260447,['RACK1'],0.7084614132922052,0,0,1
126,Mesodermal commitment pathway WP2857,0.5842506460266887,1.175521448248721,0.6317548492260447,['CEP250'],0.7084614132922052,0,0,1
127,Hippo-Merlin Signaling Dysregulation WP4541,0.5842506460266887,1.175521448248721,0.6317548492260447,['CDH2'],0.7084614132922052,0,0,1
128,Mitochondrial complex I assembly model OXPHOS system WP4324,0.6005702314722124,1.1217129977460556,0.5719341879333144,['NDUFS6'],0.7225610597400056,0,0,1
129,Adipogenesis WP236,0.616254261076045,1.0725835429392743,0.5192330157332011,['BSCL2'],0.7300242785054687,0,0,1
130,Endoderm differentiation WP2853,0.616254261076045,1.0725835429392743,0.5192330157332011,['CEP250'],0.7300242785054687,0,0,1
131,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.6313272895567383,1.0275482093663912,0.4726011388036259,['CALM1'],0.7365485044828615,0,0,1
132,Vitamin D Receptor Pathway WP2877,0.6313272895567383,1.0275482093663912,0.4726011388036259,['CLPTM1L'],0.7365485044828615,0,0,1
133,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6458129303888851,0.9861157024793389,0.43117455337429866,['PSMD5'],0.747783393081867,0,0,1
134,TYROBP causal network in microglia WP3945,0.6597338918819721,0.9478703115066751,0.3942370061044373,['IL18'],0.7582016369389828,0,0,1
135,Synaptic Vesicle Pathway WP2267,0.6731120114870848,0.9124579124579124,0.36119055839633385,['STX1A'],0.7678462945852671,0,0,1
136,Toll-like Receptor Signaling Pathway WP75,0.6859682887587113,0.8795749704840614,0.33153280941542057,['IRF3'],0.7767582093297172,0,0,1
137,TNF-alpha signaling pathway WP231,0.710195316794061,0.8203856749311295,0.2807484910597156,['CYBA'],0.7925368027991696,0,0,1
138,Ebola Virus Pathway on Host WP4217,0.710195316794061,0.8203856749311295,0.2807484910597156,['IRF3'],0.7925368027991696,0,0,1
139,Oxidative phosphorylation WP623,0.732567400330971,0.768595041322314,0.23918672168993496,['NDUFS6'],0.8116152848753228,0,0,1
140,7q11.23 copy number variation syndrome WP4932,0.7431023062819513,0.745053844227398,0.22122254243121633,['STX1A'],0.8116152848753228,0,0,1
141,Focal Adhesion WP306,0.7431023062819513,0.745053844227398,0.22122254243121633,['DIAPH1'],0.8116152848753228,0,0,1
142,Regulation of Actin Cytoskeleton WP51,0.753225479106615,0.7228974234321828,0.2048623742961552,['DIAPH1'],0.8168783364959065,0,0,1
143,Regulation of toll-like receptor signaling pathway WP1449,0.7722998664039961,0.682277318640955,0.17628843494849133,['IRF3'],0.8317075484350727,0,0,1
144,Hepatitis B infection WP4666,0.7812811900185597,0.6636140272503909,0.1637933174010285,['IRF3'],0.835536828214293,0,0,1
145,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.813825635111,0.5980649062688974,0.12320683904142983,['GPD1L'],0.8584188205965343,0,0,1
146,Ras signaling WP4223,0.813825635111,0.5980649062688974,0.12320683904142983,['CALM1'],0.8584188205965343,0,0,1
147,Myometrial relaxation and contraction pathways WP289,0.8282478760246503,0.5698635402652316,0.10738668240988393,['CALM1'],0.8676882510734433,0,0,1
148,Fragile X Syndrome  WP4549,0.8478289296427683,0.5321595400646784,0.0878469797441685,['SLC6A1'],0.8822003727363941,0,0,1
149,Calcium Regulation in the Cardiac Cell WP536,0.8651937761229628,0.49907235621521334,0.07226656477986046,['CALM1'],0.8942271243150086,0,0,1
150,IL-18 signaling pathway WP4754,0.8898738981673673,0.45209672482399754,0.05274861763215935,['IL18'],0.9136038687851638,0,0,1
151,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.902472147158979,0.42786718863273887,0.04390664031753088,['NDUFS6'],0.9204020573674356,0,0,1
152,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9170725615938143,0.399268391816827,0.0345641378561953,['PPP2R1A'],0.926580042487248,0,0,1
153,Nonalcoholic fatty liver disease WP4396,0.926580042487248,0.38016528925619836,0.028989445079384238,['NDUFS6'],0.926580042487248,0,0,1
154,PI3K-Akt signaling pathway WP4172,0.926580042487248,0.38016528925619836,0.028989445079384238,['PPP2R1A'],0.926580042487248,0,0,1
